Global Presence TCG Lifesciences has expanded beyond India with operations in the United States, Europe, and Japan, offering opportunities to partner with clients seeking international CRO and CDMO services in diverse markets.

Innovative R&D Capabilities With a broad service portfolio encompassing chemistry synthesis, pharmacology, data science, and manufacturing, TCG offers comprehensive solutions that can support pharmaceutical and biotech firms looking to outsource complex research projects.

Experienced Workforce The company boasts over 1,300 highly qualified scientists, including PhDs, providing a strong resource pool for clients requiring specialized research expertise in inflammation, infectious diseases, neurology, and oncology.

Strategic Collaborations Partnerships such as the recent collaboration with SOA indicate a focus on expanding research capabilities, offering potential avenues for joint development projects and shared innovation opportunities.

Financial Modest Scale With revenues between $25M and $50M, TCG presents a growth-focused opportunity for partners looking to engage with a mid-sized, agile organization capable of personalized service delivery and scalable solutions.